Arrowhead Pharmaceuticals
The Manager, Commercial Insights & Analytics plays a pivotal role in the commercialization of Redemplo (plozasiran), supporting its lifecycle management, launch preparedness, and post-launch performance diagnosis. This position involves conducting impactful analyses and forecasting to drive the commercial success of the cardiometabolic franchise while generating customer-focused analytical insights. The role reports directly to the Director of Commercial Insights, Analytics & Operations and is based in Pasadena, California.
Headquarters
Pasadena, California, United States
Company Size
501-1000 employees
Founded
2004
Arrowhead Pharmaceuticals is a clinical-stage biopharmaceutical company that discovers, develops, and delivers RNA interference (RNAi)-based therapeutics to silence disease-causing genes. Using proprietary targeted delivery platforms that enable focused, durable gene knockdown, Arrowhead advances programs across liver and extra‑hepatic indications including cardiometabolic, pulmonary, viral, and rare diseases. The company progresses multiple clinical and preclinical candidates and collaborates with partners to translate RNAi science into new therapies that aim to change how diseases are treated.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Arrowhead Pharmaceuticals.
Director, Commercial Insights & Analytics
lifelancer
Director, Commercial Analytics and Forecasting
Intellia Therapeutics
Executive Director, Analytics & Insights (NSCLC)
Revolution Medicines
Associate - Commercial Insights and Analytics
Amgen
Executive Director, Commercial Insights & Advanced Analytics
lifelancer
Director, Commercial Insights & Analytics
AstraZeneca